Biotech | October 22, 2021
Rakuten Medical partners with Karkinos Healthcare to expand novel cancer care in India
This strategic collaboration will enable continued innovation in cancer care
This strategic collaboration will enable continued innovation in cancer care
It has exercised intellectual property options from IP Group regarding research results generated by the UK Cystic Fibrosis Gene Therapy Consortium, and from Oxford Biomedica regarding their lentiviral vector technology
Continuum care is a concept that’s gaining acceptance in South India and Sukino Healthcare with its presence in Bangalore and Kochi has made rapid strides catering to this need. It now plans to expand to many more cities in the region. Indian Pharma Post caught up with Rajinish Menon, Founder & CEO, Sukino Healthcare who gave us an insight into the company’s operations.
The company operates four mid-sized hospitals with a total bed capacity of 556 in eastern India
Equity raise to finance growth and investments in the biological space
Everlife leads the series A round, and SPRIM Global Investments participates in the financing syndicate
Transformational partnership establishes PCI as a CDMO and broadens capabilities across drug product lifecycle
An amount of Rs. 70.9 crore has been earmarked for funding capital expenditure for the proposed expansion
The company will use the capital for building its team, product development, marketing, and setting up in-school clinics to deliver connected health to one million families
Ectosense’s NightOwl is a leading cloud-connected home sleep apnea test
Subscribe To Our Newsletter & Stay Updated
